ScholarLens Back to search
2003•Journal of Pediatric PharmacyRequires access

Pharmacoeconomics analysis on ceftriaxone and cefoperazone in treatment of children infectious disease

Bin Ni

Open publisher page 0 citations

Abstract

Objective: To evaluate pharmacoeconmics of ceftriaxone and cefoperazone in treatment of children infectious disease. Methods: Select and divide groups at random, and analyse the clinical costs and curative effect with ceftriaxone and cefoperazone. Results: The corative effect of ceftriaxone group (87.8%) was not significantly different than that of the cefoperazone group (85.4%), but clinical costs were different between ceftriaxone (1550.0±390.2 yuan) and cefoperazone (1957.8±527.6 yuan). Cost-effectiveness ratios obtained with careful analysis were 17.449 and 24.96 respectively. Conclusion: In treatment of children disease, ceftriaxone is more economical than cefoperazone.

About this research paper

What this paper is about

Objective: To evaluate pharmacoeconmics of ceftriaxone and cefoperazone in treatment of children infectious disease. Methods: Select and divide groups at random, and analyse the clinical costs and curative effect with ceftriaxone and cefoperazone. Results: The corative effect of ceftriaxone group (87.8%) was not significantly different than that of the cefoperazone group (85.4%), but clinical costs were different between ceftriaxone (1550.0±390.2 yuan) and cefoperazone (1957.8±527.6 yuan). Cost-effectiveness ratios obtained with careful analysis were 17.449 and 24.96 respectively. Conclusion: In treatment of children disease, ceftriaxone is more economical than cefoperazone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate pharmacoeconmics of ceftriaxone and cefoperazone in treatment of children infectious disease. Methods: Select and divide groups at random, and analyse the clinical costs and curative effect with ceftriaxone and cefoperazone. Results: The corative effect of ceftriaxone group (87.8%) was not significantly different than that of the cefoperazone group (85.4%), but clinical costs were different between ceftriaxone (1550.0±390.2 yuan) and cefoperazone (1957.8±527.6 yuan). Cost-effectiveness ratios obtained with careful analysis were 17.449 and 24.96 respectively. Conclusion: In treatment of children disease, ceftriaxone is more economical than cefoperazone.

Key concepts: Cefoperazone, Ceftriaxone, Medicine, Pharmacoeconomics, Internal medicine, Antibiotics, Intensive care medicine, Microbiology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Pharmacoeconomics analysis on ceftriaxone and cefoperazone in treatment of children infectious disease — Research Paper | ScholarLens